Parkside Financial Bank & Trust’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $50.8K | Hold |
267
| – | – | ﹤0.01% | 1039 |
|
|
2026
Q1 | $45.1K | Buy |
267
+1
| +0.4% | +$171 | ﹤0.01% | 997 |
|
|
2025
Q4 | $44.9K | Hold |
266
| – | – | ﹤0.01% | 1003 |
|
|
2025
Q3 | $38.4K | Buy |
266
+87
| +49% | +$11.9K | ﹤0.01% | 1028 |
|
|
2025
Q2 | $22.7K | Hold |
179
| – | – | ﹤0.01% | 1188 |
|
|
2025
Q1 | $22.9K | Buy |
179
+25
| +16% | +$3.39K | ﹤0.01% | 1106 |
|
|
2024
Q4 | $20.4K | Hold |
154
| – | – | ﹤0.01% | 1089 |
|
|
2024
Q3 | $22.4K | Hold |
154
| – | – | ﹤0.01% | 1030 |
|
|
2024
Q2 | $21.1K | Buy |
154
+109
| +242% | +$14.6K | ﹤0.01% | 1014 |
|
|
2024
Q1 | $6.19K | Buy |
45
+25
| +125% | +$3.41K | ﹤0.01% | 1289 |
|
|
2023
Q4 | $2.73K | Hold |
20
| – | – | ﹤0.01% | 1442 |
|
|
2023
Q3 | $2.45K | Hold |
20
| – | – | ﹤0.01% | 1606 |
|
|
2023
Q2 | $2.55K | Sell |
20
-1,588
| -99% | -$206K | ﹤0.01% | 1611 |
|
|
2023
Q1 | $208K | Sell |
1,608
-263
| -14% | -$34.4K | 0.06% | 227 |
|
|
2022
Q4 | $246K | Buy |
1,871
+32
| +2% | +$4.14K | 0.07% | 201 |
|
|
2022
Q3 | $215K | Sell |
1,839
-53
| -3% | -$6.58K | 0.07% | 203 |
|
|
2022
Q2 | $223K | Sell |
1,892
-184
| -9% | -$21.8K | 0.07% | 201 |
|
|
2022
Q1 | $271K | Hold |
2,076
| – | – | 0.07% | 191 |
|
|
2021
Q4 | $317K | Buy |
2,076
+1,911
| +1,158% | +$296K | 0.08% | 177 |
|
|
2021
Q3 | $27K | Hold |
165
| – | – | 0.01% | 685 |
|
|
2021
Q2 | $27K | Hold |
165
| – | – | 0.01% | 682 |
|
|
2021
Q1 | $25K | Buy |
165
+14
| +9% | +$2.22K | 0.01% | 694 |
|
|
2020
Q4 | $23K | Hold |
151
| – | – | 0.01% | 678 |
|
|
2020
Q3 | $20K | Hold |
151
| – | – | 0.01% | 643 |
|
|
2020
Q2 | $21K | Hold |
151
| – | – | 0.01% | 627 |
|
|
2020
Q1 | $16K | Hold |
151
| – | – | 0.01% | 611 |
|
|
2019
Q4 | $18K | Buy |
151
+2
| +1% | +$223 | 0.01% | 683 |
|
|
2019
Q3 | $15K | Sell |
149
-155
| -51% | -$16.2K | ﹤0.01% | 698 |
|
|
2019
Q2 | $33K | Hold |
304
| – | – | 0.01% | 493 |
|
|
2019
Q1 | $34K | Hold |
304
| – | – | 0.01% | 466 |
|
|
2018
Q4 | $29K | Buy |
+304
| New | +$32.3K | 0.01% | 478 |
|
|
2017
Q1 | – | Sell |
-360
| Closed | -$32K | – | 1424 |
|
|
2016
Q4 | $32K | Hold |
360
| – | – | 0.01% | 424 |
|
|
2016
Q3 | $35K | Hold |
360
| – | – | 0.02% | 446 |
|
|
2016
Q2 | $31K | Buy |
+360
| New | +$32.3K | 0.02% | 442 |
|
Other funds holding IBB
CB
Parkside Financial Bank & Trust's IBB Position: Q2 2026 in Review
Parkside Financial Bank & Trust held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 267 shares worth $50.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1039.
Parkside Financial Bank & Trust first reported a position in IBB in Q2 2016 and has held it in 34 quarters since. The position peaked at $317K in Q4 2021. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Parkside Financial Bank & Trust held 267 shares of iShares Biotechnology ETF worth $50.8K as of Q2 2026.
- Parkside Financial Bank & Trust left its iShares Biotechnology ETF share count unchanged in Q2 2026.
- iShares Biotechnology ETF made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1039 holding.
- Parkside Financial Bank & Trust first reported a position in iShares Biotechnology ETF in Q2 2016 and has held it in 34 quarters since.
- Parkside Financial Bank & Trust's iShares Biotechnology ETF position peaked at $317K in Q4 2021.
- 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.